Home LiteratureArticle Details
PMID: 17332893 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.

The Journal of clinical investigation ·Vol. 117 ·No. 3 ·2007-03-00 ·Pages 746-56

Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW

Abstract

HDL lowers the risk for atherosclerotic cardiovascular disease by promoting cholesterol efflux from macrophage foam cells. However, other antiatherosclerotic properties of HDL are poorly understood. To test the hypothesis that the lipoprotein carries proteins that might have novel cardioprotective activities, we used shotgun proteomics to investigate the composition of HDL isolated from healthy subjects and subjects with coronary artery disease (CAD). Unexpectedly, our analytical strategy identified multiple complement-regulatory proteins and a diverse array of distinct serpins with serine-type endopeptidase inhibitor activity. Many acute-phase response proteins were also detected, supporting the proposal that HDL is of central importance in inflammation. Mass spectrometry and biochemical analyses demonstrated that HDL3 from subjects with CAD was selectively enriched in apoE, raising the possibility that HDL carries a unique cargo of proteins in humans with clinically significant cardiovascular disease. Collectively, our observations suggest that HDL plays previously unsuspected roles in regulating the complement system and protecting tissue from proteolysis and that the protein cargo of HDL contributes to its antiinflammatory and antiatherogenic properties.

MeSH Terms
Amino Acid Sequence Chromatography, Liquid Complement Activation Coronary Artery Disease/enzymology,immunology Humans Inflammation/metabolism Lipid Metabolism Lipoproteins, HDL/blood,isolation & purification,metabolism Mass Spectrometry Microscopy, Electron, Scanning Molecular Sequence Data Peptide Hydrolases/metabolism Proteomics
Chemicals
Lipoproteins, HDL Peptide Hydrolases
Authors & Affiliations
21 authors, click to expand affiliations / ORCID
Vaisar Tomas
Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195, USA.
Pennathur Subramaniam
Green Pattie S
Gharib Sina A
Hoofnagle Andrew N
Cheung Marian C
Byun Jaeman
Vuletic Simona
Kassim Sean
Singh Pragya
Chea Helen
Knopp Robert H
Brunzell John
Geary Randolph
Chait Alan
Zhao Xue-Qiao
Elkon Keith
Marcovina Santica
Ridker Paul
Oram John F
Heinecke Jay W
References (66)
66 references, click to expand
  1. Human peripheral blood monocyte-derived macrophages produce haemolytically active C3 in vitro.
    Immunology. 1983 May;49(1):169-74 PMID: 6840804
  2. Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: role of apoE.
    Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):129-35 PMID: 11145944
  3. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
    N Engl J Med. 2006 Jun 15;354(24):2552-63 PMID: 16775236
  4. Targeting C-reactive protein for the treatment of cardiovascular disease.
    Nature. 2006 Apr 27;440(7088):1217-21 PMID: 16642000
  5. Identifying biological themes within lists of genes with EASE.
    Genome Biol. 2003;4(10):R70 PMID: 14519205
  6. High-density lipoprotein--the clinical implications of recent studies.
    N Engl J Med. 1989 Nov 9;321(19):1311-6 PMID: 2677733
  7. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Curr Opin Lipidol. 2004 Jun;15(3):261-7 PMID: 15166781
  8. Investigation of an albumin-enriched fraction of human serum and its albuminome.
    Proteomics Clin Appl. 2007 Jan 1;1(1):73-88 PMID: 20204147
  9. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway.
    J Clin Invest. 2006 May;116(5):1435-42 PMID: 16670775
  10. Direct analysis of protein complexes using mass spectrometry.
    Nat Biotechnol. 1999 Jul;17(7):676-82 PMID: 10404161
  11. Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex.
    J Biol Chem. 2004 Sep 10;279(37):38079-82 PMID: 15151994
  12. Proteomic analysis of high-density lipoprotein.
    Proteomics. 2006 Jan;6(2):721-30 PMID: 16419016
  13. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.
    Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6993-7 PMID: 1495991
  14. Regulation and mechanisms of macrophage cholesterol efflux.
    J Clin Invest. 2002 Oct;110(7):899-904 PMID: 12370265
  15. Putting cholesterol in its place: apoE and reverse cholesterol transport.
    J Clin Invest. 2006 May;116(5):1226-9 PMID: 16670767
  16. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
    JAMA. 2001 Jul 4;286(1):64-70 PMID: 11434828
  17. Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease.
    Clin Chim Acta. 1993 Nov 15;220(2):175-87 PMID: 8111962
  18. Molecular regulation of HDL metabolism and function: implications for novel therapies.
    J Clin Invest. 2006 Dec;116(12):3090-100 PMID: 17143322
  19. Creating the gene ontology resource: design and implementation.
    Genome Res. 2001 Aug;11(8):1425-33 PMID: 11483584
  20. Role of complement activation in atherosclerosis.
    Curr Opin Lipidol. 2003 Oct;14(5):477-82 PMID: 14501586
  21. A macro and micro view of coronary vascular insult in ischemic heart disease.
    Circulation. 1990 Sep;82(3 Suppl):II38-46 PMID: 2203563
  22. Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L.
    J Biol Chem. 1997 Oct 10;272(41):25576-82 PMID: 9325276
  23. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
    Proteomics. 2005 Aug;5(13):3226-45 PMID: 16104056
  24. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2267-74 PMID: 11031214
  25. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.
    Curr Opin Cardiol. 2006 Jul;21(4):322-8 PMID: 16755201
  26. High density lipoprotein cholesterol and mortality. The Framingham Heart Study.
    Arteriosclerosis. 1988 Nov-Dec;8(6):737-41 PMID: 3196218
  27. Deaths: preliminary data for 2003.
    Natl Vital Stat Rep. 2005 Feb 28;53(15):1-48 PMID: 15779680
  28. Antiinflammatory properties of HDL.
    Circ Res. 2004 Oct 15;95(8):764-72 PMID: 15486323
  29. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins.
    Clin Chem. 2005 Feb;51(2):351-9 PMID: 15528295
  30. Comparison of label-free methods for quantifying human proteins by shotgun proteomics.
    Mol Cell Proteomics. 2005 Oct;4(10):1487-502 PMID: 15979981
  31. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.
    J Clin Invest. 2004 Aug;114(4):529-41 PMID: 15314690
  32. Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology.
    Anal Chem. 2003 Oct 1;75(19):5054-61 PMID: 14708778
  33. Fibrinogen is a component of a novel lipoprotein particle: factor H-related protein (FHRP)-associated lipoprotein particle (FALP).
    Blood. 2000 Jan 1;95(1):198-204 PMID: 10607703
  34. The International Protein Index: an integrated database for proteomics experiments.
    Proteomics. 2004 Jul;4(7):1985-8 PMID: 15221759
  35. Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I.
    Proc Natl Acad Sci U S A. 1984 Mar;81(5):1356-60 PMID: 6424116
  36. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.
    Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):13032-7 PMID: 15326314
  37. A novel human apolipoprotein (apoM).
    J Biol Chem. 1999 Oct 29;274(44):31286-90 PMID: 10531326
  38. Proteomics strategies for protein identification.
    FEBS Lett. 2005 Feb 7;579(4):885-9 PMID: 15680968
  39. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol.
    J Biol Chem. 1991 Jun 5;266(16):10104-11 PMID: 1645339
  40. The role of complement activation in atherosclerosis.
    Immunol Res. 2004;30(1):73-80 PMID: 15258311
  41. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species.
    J Biol Chem. 2004 Oct 8;279(41):42977-83 PMID: 15292228
  42. Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography.
    J Lipid Res. 1987 Aug;28(8):913-29 PMID: 3117954
  43. Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes.
    J Biol Chem. 2005 Sep 23;280(38):32578-85 PMID: 16046400
  44. Identification, characterization, cloning, and expression of apolipoprotein C-IV, a novel sialoglycoprotein of rabbit plasma lipoproteins.
    J Biol Chem. 1996 Jan 19;271(3):1776-83 PMID: 8576182
  45. Human apoC-IV: isolation, characterization, and immunochemical quantification in plasma and plasma lipoproteins.
    J Lipid Res. 2003 Jul;44(7):1387-94 PMID: 12700345
  46. Virtual two-dimensional gel electrophoresis of high-density lipoproteins.
    Electrophoresis. 2004 Jul;25(14):2384-91 PMID: 15274021
  47. Diverse range of small peptides associated with high-density lipoprotein.
    Biochem Biophys Res Commun. 2006 Feb 17;340(3):909-15 PMID: 16386709
  48. High density lipoprotein subfractions: isolation, composition, and their duplicitous role in oxidation.
    J Lipid Res. 2007 Jan;48(1):86-95 PMID: 17065664
  49. A model for random sampling and estimation of relative protein abundance in shotgun proteomics.
    Anal Chem. 2004 Jul 15;76(14):4193-201 PMID: 15253663
  50. Identification of proteins associated with apolipoprotein A-I-containing lipoproteins purified by selected-affinity immunosorption.
    Biochemistry. 1994 Mar 1;33(8):1988-93 PMID: 8117655
  51. Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins.
    Proteomics. 2005 Jul;5(10):2619-30 PMID: 15892164
  52. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    J Neurosci Res. 2005 May 1;80(3):406-13 PMID: 15795933
  53. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.
    N Engl J Med. 1997 Nov 6;337(19):1360-9 PMID: 9358131
  54. Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement. Affinity of the apoproteins for polymeric C9.
    J Biol Chem. 1993 Feb 15;268(5):3632-8 PMID: 8429039
  55. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.
    Proteomics. 2005 Apr;5(5):1431-45 PMID: 15761960
  56. A statistical model for identifying proteins by tandem mass spectrometry.
    Anal Chem. 2003 Sep 1;75(17):4646-58 PMID: 14632076
  57. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
    J Lipid Res. 2004 Jun;45(6):993-1007 PMID: 15060092
  58. Serpins, the vasculature, and viral therapeutics.
    Front Biosci. 2006;11:1042-56 PMID: 16146796
  59. Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subpopulations.
    J Lipid Res. 1988 Jan;29(1):15-25 PMID: 3128619
  60. A dataset of human liver proteins identified by protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry.
    Mol Cell Proteomics. 2004 Oct;3(10):1039-41 PMID: 15269248
  61. Unique lipoprotein phenotype and genotype associated with exceptional longevity.
    JAMA. 2003 Oct 15;290(15):2030-40 PMID: 14559957
  62. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies.
    BMC Bioinformatics. 2004 Feb 18;5:16 PMID: 14975175
  63. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation.
    J Biol Chem. 2000 Oct 27;275(43):33435-42 PMID: 10931838
  64. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.
    J Clin Invest. 1990 Jan;85(1):10-7 PMID: 2295691
  65. Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
    J Lipid Res. 2005 Mar;46(3):389-403 PMID: 15722558
  66. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta.
    J Biol Chem. 2002 Aug 30;277(35):31900-8 PMID: 12032151
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2007-03-00
Pages
746-56
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC1804352
Subset
IM
Grants
NHLBI NIH HHS · P01HL030086 · United States
NHLBI NIH HHS · P01 HL030086 · United States
NIDDK NIH HHS · DK017047 · United States
NIDDK NIH HHS · DK02456 · United States
NHLBI NIH HHS · HL57557 · United States
NHLBI NIH HHS · R01 HL078527 · United States
NIEHS NIH HHS · P30ES07033 · United States
NHLBI NIH HHS · R01 HL057557 · United States
NHLBI NIH HHS · HL078527 · United States
NHLBI NIH HHS · R01 HL086798 · United States
NIEHS NIH HHS · P30 ES007033 · United States
NHLBI NIH HHS · HL086798 · United States
NHLBI NIH HHS · HL074223 · United States
NIDDK NIH HHS · P01 DK002456 · United States
NHLBI NIH HHS · K08 HL074223 · United States
NIDDK NIH HHS · P30DK017047 · United States
NIDDK NIH HHS · P30 DK017047 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com